Overview
Parkinson's disease is a chronic, progressive neurodegenerative disorder caused principally by the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of alpha-synuclein aggregates known as Lewy bodies. The resulting dopamine deficiency within the basal ganglia produces the cardinal motor features of bradykinesia, resting tremor, rigidity, and postural instability, alongside non-motor manifestations including cognitive, autonomic, and neuropsychiatric symptoms such as impulse control disorders. The disease is diagnosed clinically and managed through dopaminergic therapy, with advanced cases addressed by device-aided treatments. Research in this area examines deep brain stimulation of the subthalamic nucleus, including segmented-electrode strategies to reduce side effects, and compares continuous infusion therapies such as apomorphine and levodopa-carbidopa formulations. Further work analyses gait and muscle-activation signals, plasma homocysteine and vascular markers, the prevalence of impulse control disorders, and defective molecular pathways and neurotoxicity models relevant to pathogenesis. Allied strands consider music-based and adjunctive approaches in neurology and the contribution of diet and the microbiota. Symptomatic treatment and quality of life remain central, as no disease-modifying cure exists. The journal publishes peer-reviewed research on Parkinson's disease, including deep brain stimulation, pharmacotherapy, gait analysis, and pathway and neurotoxicity studies.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Effect of Medical Theraphy on Plasma Homocysteine Levels and Carotid Intima-Media Thickness in Parkinson's Disease
Short-Term Outcomes of Deep Brain Stimulation of the Subthalamic Nucleus in Patients with Parkinson’s Disease - Pilot Study
Muscle Activation Signals During Gait Parkinson’s Disease are More Rhythmic than in Healthy Controls
Robust Sampling of Defective Pathways in Parkinson Disease
Reduction of Side Effects by Segmented Electrodes in Case of Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease: A Case Report.
Epigenetics and Nutrition
Why Music in Neurology?
Evaluation of Anti-Aging Activity of the Biofield Energy Treated Novel Test Formulation Using SIRT1 and Telomerase Activity in in Vitro Model
How Knowledge on Microbiota may be Helpful to Establish an Optimal Diet for Health Maintenance
Ameliorative Potential of Chlorogenic Acid on Rotenone-Induced Neurotoxicity in Drosophila Melanogaster Model
How this research is being cited
The 12 articles above have been cited 34 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Journal of Neurogenetics
-
2026 · Advances in Biomarker Sciences and Technology
-
2025 · Basic & Clinical Pharmacology & Toxicology
-
2025 · Case Reports in Neurology
-
2025 · Basic & Clinical Pharmacology & Toxicology
-
2025 · Case Reports in Neurology
-
2025 · Current Traditional Medicine
-
2024 ·
A sample of recent works citing this journal's research on Parkinson's Disease, linking to each citing work.